Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
BC Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada.
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6969-6974. doi: 10.1073/pnas.1819023116. Epub 2019 Mar 18.
Sudden unexpected death of an infant (SUDI) is a devastating occurrence for families. To investigate the genetic pathogenesis of SUDI, we sequenced >70 genes from 191 autopsy-negative SUDI victims. Ten infants sharing a previously unknown variant in troponin I (TnI) were identified. The mutation ( R37C) is in the fetal/neonatal paralog of TnI, a gene thought to be expressed in the heart up to the first 24 months of life. Using phylogenetic analysis and molecular dynamics simulations, it was determined that arginine at residue 37 in may play a critical functional role, suggesting that the variant may be pathogenic. We investigated the biophysical properties of the R37C mutation in human reconstituted thin filaments (RTFs) using fluorometry. RTFs reconstituted with the mutant R37C TnI exhibited reduced Ca-binding sensitivity due to an increased Ca off-rate constant. Furthermore, we generated R37C mutants in human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) using CRISPR-Cas9. In monolayers of hiPSC-CMs, we simultaneously monitored voltage and Ca transients through optical mapping and compared them to their isogenic controls. We observed normal intrinsic beating patterns under control conditions in R37C at stimulation frequencies of 55 beats/min (bpm), but these cells showed no restitution with increased stimulation frequency to 65 bpm and exhibited alternans at >75 bpm. The WT hiPSC-CMs did not exhibit any sign of arrhythmogenicity even at stimulation frequencies of 120 bpm. The approach used in this study provides critical physiological and mechanistic bases to investigate sarcomeric mutations in the pathogenesis of SUDI.
婴儿猝死(SUDI)是一个毁灭性的事件,会给家庭带来极大的痛苦。为了研究 SUDI 的遗传发病机制,我们对 191 例尸检阴性的 SUDI 患者的>70 个基因进行了测序。发现了 10 名婴儿共享一个以前未知的肌钙蛋白 I(TnI)变体。该突变(R37C)位于 TnI 的胎儿/新生儿同工型中,该基因被认为在生命的头 24 个月内表达于心脏。通过系统发生分析和分子动力学模拟,确定第 37 位精氨酸在 TnI 中可能发挥关键的功能作用,表明该变体可能是致病性的。我们使用荧光法研究了人类重组细肌丝(RTFs)中 R37C 突变的生物物理特性。用突变 R37C TnI 重组的 RTFs 由于 Ca 释放率常数增加,导致 Ca 结合敏感性降低。此外,我们使用 CRISPR-Cas9 在人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)中生成 R37C 突变体。在 hiPSC-CMs 的单层中,我们通过光学绘图同时监测电压和 Ca 瞬变,并将其与同基因对照进行比较。在 55 次/分钟(bpm)的刺激频率下,R37C 在对照条件下显示正常的固有搏动模式,但这些细胞在刺激频率增加到 65 bpm 时没有复极,并且在>75 bpm 时表现出交替。WT hiPSC-CMs 在 120 bpm 的刺激频率下甚至没有表现出心律失常的迹象。本研究中使用的方法为研究肌节突变在 SUDI 发病机制中的作用提供了重要的生理和机制基础。